|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
540,054 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,092,104 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,587 |
|
|
Total
Value |
$65,030,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
853 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 15 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-30 |
4 |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
129,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-03-09 |
4 |
OE |
$6.47 |
$97,050 |
D/D |
15,000 |
129,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-27 |
4 |
S |
$28.00 |
$8,120 |
D/D |
(290) |
129,803 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-25 |
4/A |
S |
$26.94 |
$26,944 |
D/D |
(1,000) |
130,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-12 |
4 |
OE |
$6.46 |
$19,380 |
D/D |
3,000 |
130,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
131,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-07-14 |
4 |
AS |
$30.00 |
$30,000 |
D/D |
(1,000) |
131,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
132,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-01 |
4 |
OE |
$9.86 |
$197,200 |
D/D |
20,000 |
133,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-04-27 |
4 |
OE |
$9.86 |
$197,200 |
D/D |
20,000 |
134,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-02 |
4 |
OE |
$6.46 |
$25,840 |
D/D |
4,000 |
135,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Business Officer |
|
2012-10-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
13,545 |
135,901 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Business Officer |
|
2012-05-12 |
5 |
D |
$38.00 |
$297,160 |
D/D |
(7,820) |
149,446 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-01-23 |
4 |
AS |
$55.22 |
$220,880 |
D/D |
(4,000) |
153,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-02-04 |
4 |
AS |
$55.77 |
$111,532 |
D/D |
(2,000) |
153,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-02-04 |
4 |
OE |
$12.99 |
$25,980 |
D/D |
2,000 |
155,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-01-22 |
4 |
AS |
$55.00 |
$550,000 |
D/D |
(10,000) |
157,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-11-09 |
4 |
S |
$48.42 |
$96,844 |
D/D |
(2,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-11-14 |
4 |
S |
$48.50 |
$193,987 |
D/D |
(4,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-11-16 |
4 |
S |
$48.05 |
$384,366 |
D/D |
(8,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-04 |
4 |
S |
$47.94 |
$239,692 |
D/D |
(5,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-07 |
4 |
AS |
$47.04 |
$141,123 |
D/D |
(3,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-10 |
4 |
AS |
$48.03 |
$144,084 |
D/D |
(3,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-12 |
4 |
AS |
$50.00 |
$250,000 |
D/D |
(5,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-21 |
4 |
AS |
$48.57 |
$437,137 |
D/D |
(9,000) |
167,691 |
0 |
- |
|
853 Records found
|
|
Page 15 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|